LONDON, April 23 (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a ...
A row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday over patents for COVID vaccine technology that helped save millions of lives during the pandemic.
One of the world’s top vaccine-makers is partnering with a major AI company to advance medicine — and its chief executive is excited. Moderna and OpenAI announced an ongoing partnership ...
Stéphane Bancel, Moderna’s chief executive, told the Journal the partnership will be key to advancing the vaccine-maker’s business process as it moves beyond the COVID-19 vaccine to produce ...
So much so that Moderna CEO Stéphane Bancel says his staff should be making the most of the investment in AI and using it a lot. More than "a lot." Bancel's suggestion: More than 20 times a day.
AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause a rare side effect, in an apparent about-turn that could pave the way for a multi-million pound ...
Verizon has another price increase on the way. In an email to customers on Thursday, the company revealed a $5 per month price increase affecting plans tied to Apple Watch and other connected ...
“Just as the introduction of the personal computer in the 1980s changed the way we work and live, AI is on a path to completely transform our everyday lives — and OpenAI is helping to lead the way,” ...
News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...
According to a new report from The Verge, Microsoft is once again considering a price increase for the subscription service. Nothing has been confirmed at this time, but sources for the report ...